Nimbus raises $125M to advance rival to Bristol Myers’ new psoriasis drug

Nimbus raises $125M to advance rival to Bristol Myers’ new psoriasis drug

Source: 
BioPharma Dive
snippet: 

Nimbus Therapeutics has raised $125 million in fresh funding to bring its top drug prospect into late-stage clinical testing.